Paul Hartig

11.0k citations

81 papers · 8.7k indexed · 1 hit paper · h-index 40

Cellular and Molecular Neuroscience top 0.1%
Molecular Biology top 1%
Physiology top 2%
Psychiatry and Mental health top 2%
Pharmacology top 1%

Co-authors: P.P.A. Humphrey Daniël Hoyer Richard L. Weinshank Graeme R. Martin David E. Clarke John R. Fozard P.R. Saxena Ewan J. Mylecharane
Topics: Neurotransmitter Receptor Influence on Behavior (35 papers)Receptor Mechanisms and Signaling (30 papers)Neuroscience and Neuropharmacology Research (19 papers)
Cited by: Cellular and Molecular Neuroscience Biological Psychiatry Behavioral Neuroscience
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Neuron
Partner nations: United States Germany United Kingdom

In The Last Decade

Paul Hartig

80 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

1994 2.6k citations Daniël Hoyer, David E. Clarke et al. Pharmacological Reviews profile →

Peers

Countries citing papers authored by Paul Hartig

Since Specialization

Citations

This map shows the geographic impact of Paul Hartig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Hartig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Hartig more than expected).

Fields of papers citing papers by Paul Hartig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Hartig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Hartig. The network helps show where Paul Hartig may publish in the future.

Co-authorship network of co-authors of Paul Hartig

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Hartig. A scholar is included among the top collaborators of Paul Hartig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Hartig. Paul Hartig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anxiolytic-Like Effects of the Corticotropin-Releasing Factor1 (CRF1) Antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] Administered Acutely or Chronically at Doses Occupying Central CRF1 Receptors in Rats 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Snježana Lelas,Harvey Wong,Yu-Wen Li,Karen Heman,Kate A. Ward,(unknown),(unknown),(unknown),Helen E. Godonis,(unknown),Xiao‐Xin Yan,Stephen P. Arnerić,David W. Robertson,Paul Hartig,Scott Grossman,George L. Trainor,Rebecca Taub,Robert Zaczek,Paul J. Gilligan,John F. McElroy	47
2	Imidazo[4,5-c]pyridines as corticotropin releasing factor receptor ligands 2003 ·Bioorganic & Medicinal Chemistry Letters ·Argyrios G. Arvanitis,(unknown),(unknown),Richard G. Wilde,Lawrence W. Fitzgerald,Robert Zaczek,Paul Hartig,Scott Grossman,Stephen P. Arnerić,Paul J. Gilligan,Richard E. Olson,David W. Robertson	7
3	Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands 2003 ·Bioorganic & Medicinal Chemistry Letters ·Argyrios G. Arvanitis,(unknown),(unknown),Richard G. Wilde,Gary A. Cain,(unknown),(unknown),Christopher A. Teleha,Lawrence W. Fitzgerald,John Mcelroy,Robert Zaczek,Paul Hartig,Scott Grossman,Stephen P. Arnerić,Paul J. Gilligan,Richard E. Olson,David W. Robertson	11
4	Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor 2001 ·Molecular Brain Research ·Siew Peng Ho,Lorey K. Takahashi,(unknown),(unknown),(unknown),Carla Maciag,Mark A. Smith,Kenneth W. Rohrbach,Paul Hartig,Stephen P. Arnerić	64
5	Intrastriatal and intraventricular injections of oligodeoxynucleotides in the rat brain: tissue penetration, intracellular distribution and c-fos antisense effects 1998 ·Molecular Brain Research ·Reinhard Grzanna,(unknown),Gersham Dent,Zhongqi Ji,Wei Zhang,Siew Peng Ho,Paul Hartig	29
6	Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes 1996 ·Trends in Pharmacological Sciences ·Paul Hartig,Daniël Hoyer,P.P.A. Humphrey,Graeme R. Martin	206
7	Serotonin 5‐HT_2C Receptor Stimulates Cyclic GMP Formation in Choroid Plexus 1995 ·Journal of Neurochemistry ·Marc J. Kaufman,Paul Hartig,Beth J. Hoffman	47
8	International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).breakdown → 1994 ·Pharmacological Reviews ·Daniël Hoyer,David E. Clarke,John R. Fozard,Paul Hartig,Graeme R. Martin,Ewan J. Mylecharane,P.R. Saxena,P.P.A. Humphrey	2558
9	A proposed new nomenclature for 5-HT receptors 1993 ·Trends in Pharmacological Sciences ·P.P.A. Humphrey,Paul Hartig,Daniël Hoyer	465
10	Serotonin Receptor Subtypes 1993 ·PubMed ·Paul Hartig,Nika Adham,J M Zgombick,M Macchi,Hung‐Teh Kao,Lee E. Schechter,T. A. Branchek,Richard L. Weinshank	10
11	A subfamily of 5-HT1D receptor genes 1992 ·Trends in Pharmacological Sciences ·Paul Hartig,Theresa A. Branchek,Richard L. Weinshank	187
12	Correlation of ¹²⁵I‐LSD autoradiographic labeling with serotonin voltage clamp responses in Aplysia neurons 1991 ·Synapse ·Martyn L. Evans,Michael J. Kadan,Paul Hartig,David O. Carpenter	4
13	Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor. 1990 ·Molecular Pharmacology ·Richard L. Weinshank,J M Zgombick,M Macchi,Nika Adham,H. Lichtblau,T A Branchek,Paul Hartig	95
14	Synthesis and in vivo characterization of d-(+)-(N1-[11C]methyl)-2-Br-LSD: a radioligand for positron emission tomographic studies of serotonin 5-HT2 receptors 1989 ·International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·John R. Lever,Robert F. Dannals,Alan A. Wilson,Hayden T. Ravert,Ursula Scheffel,Beth J. Hoffman,Paul Hartig,Dean F. Wong,Henry N. Wagner	7
15	In Vivo Labeling of Serotonin Uptake Sites with [³H]Paroxetine 1989 ·Journal of Neurochemistry ·Ursula Scheffel,Paul Hartig	50
16	Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex 1988 ·Brain Research ·Mary E. Blue,Keith A. Yagaloff,Laura A. Mamounas,Paul Hartig,Mark E. Molliver	164
17	Autoradiographic localization and characterization of [125I]Lysergic acid diethylamide binding to serotonin receptors in Aplysia 1988 ·Neuroscience ·Maura Kadan,Paul Hartig	17
18	Localization of serotonin 5‐HT₂ receptors in living human brain by positron emission tomography using N1‐([¹¹C]‐methyl)‐2‐BR‐LSD 1987 ·Synapse ·Dean F. Wong,John R. Lever,Paul Hartig,Robert F. Dannals,Victor L. Villemagne,Beth J. Hoffman,(unknown),Hayden T. Ravert,Jonathan M. Links,Ursula Scheffel,Henry N. Wagner	78
19	Unique serotonin receptor (5HT-1C) in choroid plexus is linked to phosphoinositide hydrolysis 1986 ·Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) ·Elaine Sanders‐Bush,P. Jeffrey Conn,Beth J. Hoffman,Paul Hartig	1
20	[125I]LSD binding to serotonin and dopamine receptors in bovine caudate membranes 1985 ·Neurochemistry International ·Paul Hartig,Mark J. Evans,(unknown),Sara Leder,Ping Sze,Doris A. Stoffers	16

About Paul Hartig

Paul Hartig is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Biological Psychiatry, having authored 81 papers that have together received 8.7k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (35 papers), Receptor Mechanisms and Signaling (30 papers) and Neuroscience and Neuropharmacology Research (19 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (5.2k citations), Biological Psychiatry (255 citations) and Behavioral Neuroscience (348 citations). Paul Hartig has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include P.P.A. Humphrey, Daniël Hoyer, Richard L. Weinshank, Graeme R. Martin, David E. Clarke, John R. Fozard, P.R. Saxena, Ewan J. Mylecharane, T. A. Branchek and Laurence A. Borden. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Neuron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact